Our Advance 2025 strategy builds on Corbion’s fundamental strengths by focusing our business portfolio in alignment with global market trends. To achieve this ambition, we invest in key growth areas such as natural food preservation, algae-based ingredients, lactic acid derivatives, and natural polymers.
Aligned with our purpose, "to preserve what matters," sustainability is at the heart of everything we do. Our commitment to delivering value for customers also addresses the pressing global need for more sustainable products and solutions.
We have aligned our Advance 2025 strategy with the United Nations Sustainable Development Goals, specifically SDG 2 (Zero hunger), SDG 3 (Good health and well-being), and SDG 12 (Responsible consumption and production). These are the goals where we believe we can create the most significant impact, given our footprint, the nature of our business, and the environment in which we operate.
In January 2024, during the Capital Markets Update Corbion announced a simplified organizational structure comprising two business units:
The transition involves integrating our incubator into core reporting segments, enhancing R&D accountability, and fostering stronger connections to key business objectives.
This restructuring aims to enhance Corbion's agility, responsiveness, and success in meeting market demands and driving innovation.
Health & Nutrition comprises three segments: Nutrition (including omega-3), Pharma, and Biomedical polymer markets. With $245 million in sales, the unit accounts for roughly 20% of Corbion’s overall portfolio. Being a global supplier firmly committed to improving health and nutrition for humans and animals, we focus our capabilities to meet diverse market needs.
Our line of omega-3 ingredients for enhancing nutrition sustainably bridges the demand-supply gap for essential fatty acids across aquaculture, pet, and human nutrition sectors. While the business unit’s nutrition focus has primarily centered around omega-3 in aquaculture, current expansion into pet and human nutrition, and diversification through the development of new nutrients, enables us to enter higher-growth/margin markets and deliver maximum value.
In addition, we produce highest-quality medical biopolymers and pharmaceutical solutions to meet specific needs in targeted, patient-friendly medical applications.
Functional Ingredients & Solutions
Functional Ingredients & Solutions, surpassing $1 billion in sales and representing about 80% of our portfolio, comprises three segments: Food, Biochemicals, and Lactic Acid to PLA.
As a global supplier of advanced ingredient solutions, we address challenges for the world’s leading manufacturers worldwide, utilizing products from our diverse portfolio. We are known as a fermentation powerhouse, excelling in adaptive and tailored blending capabilities, and providing effective, natural alternatives to synthetic ingredients. We have earned our reputation for deep application expertise, reinforced by our state-of-the-art application labs and dedicated technical support teams, catering to the needs of a broad customer base across food and biochemical markets.
The core of the business unit is focused on the food ingredient sector, accounting for about ¾ of our business. Another 18% serves the biochemical sector, and 6% supports our lactic acid joint venture.
We use our advanced fermentation capabilities and extensive blending expertise worldwide to create blends, systems, and solutions tailored to meet the needs of our diverse customers. Central to our strategy is the replacement of synthetic and artificial ingredients with effective, natural alternatives in both the food and biochemical sectors, supported by top-tier application and technical support services.
The business unit competes in stable markets where we maintain prominent positions, especially in natural preservation and functional systems. Whether supplying natural solvents to the electronics industry or exploring organic acid derivatives and functional blends, we consistently deliver added value to our customers.